Results 71 to 80 of about 7,222 (160)

The Clinical and Metabolic Profiles in Menstrual Changes Among Reproductive‐Aged Women Post‐COVID‐19

open access: yesMedComm, Volume 6, Issue 6, June 2025.
This study recruited 253 Chinese women of reproductive age and post‐COVID‐19 infection. Serious factors, including age and perceived stress, contribute to menstrual changes while general medical condition was the only independent risk factor. Notable metabolic change existed in group with any menstruation changes, with special sex hormone: T decreased ...
Wei Wang   +13 more
wiley   +1 more source

Tuberculosis Trends in the Post‐COVID‐19 Era: Is It Going to be a Global Concern?

open access: yesHealth Science Reports, Volume 8, Issue 5, May 2025.
ABSTRACT Background and Aims Tuberculosis (TB), a leading cause of death from infectious diseases, faced considerable challenges during the coronavirus disease 2019 (COVID‐19) pandemic. This review examines the impact of pandemic‐related disruptions, including the diversion of healthcare resources, reduced access to TB diagnostics and treatment, and ...
Soroush Khojasteh‐Kaffash   +5 more
wiley   +1 more source

Fulminant Type 1 Diabetes Mellitus With Concomitant Coxsackievirus B6 Antibody Elevation and RNA‐Based COVID‐19 Vaccination: A Case Report and Review of the Literature

open access: yesClinical Case Reports, Volume 13, Issue 4, April 2025.
ABSTRACT Fulminant type 1 diabetes is a rare but severe condition that can develop rapidly, often in association with viral infections. In this case, coxsackievirus B6 antibody levels were elevated after disease onset, though its significance remains unclear.
Hisaka Minami   +10 more
wiley   +1 more source

A Randomized Clinical Trial Using CoronaVac or BNT162b2 Vaccine as a Third Dose in Adults Vaccinated with Two Doses of CoronaVac [PDF]

open access: yesAmerican Journal of Respiratory and Critical Care Medicine, 2022
Chris Ka Pun Mok   +9 more
openaire   +2 more sources

Eosinophils and COVID‐19: Insights into immune complexity and vaccine safety

open access: yesClinical and Translational Allergy, Volume 15, Issue 3, March 2025.
Abstract Background COVID‐19 exhibits a variety of symptoms and may lead to multi‐organ failure and death. This clinical complexity is exacerbated by significant immune dysregulation affecting nearly all cells of the innate and adaptive immune system. Granulocytes, including eosinophils, are affected by SARS‐CoV‐2.
Wided Sahli, Joana Vitte, Benoit Desnues
wiley   +1 more source

Correlation Between Knowledge Level On Anxiety Level Post-Coronavac Vaccine at The Clinic of dr. Irma

open access: yes, 2021
Vaccination is the government\u27s effort to prevent the spread of the COVID-19 pandemic. Lack of knowledge about the Coronavac vaccine gives rise to various kinds of speculation, resulting in anxiety.
Aulia, Yusrin, Ilahi, Marintik
core  

Adverse events associated with CoronaVac in a university hospital

open access: yesRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2022
Objective: The present study aimed to describe suspected adverse events (AEs) reported in employees of a teaching hospital in the state of Sergipe after vaccination with CoronaVac. Methods: This is a cross-sectional study based on reports of post-vaccination adverse event notification forms (APVs) from the Hospital Surveillance application (Vigihosp ...
Lana N. SILVA-SANTOS   +6 more
openaire   +1 more source

DataSheet_1_Longitudinal evaluation of innate immune responses to three doses of CoronaVac vaccine.docx

open access: yes, 2023
The adaptive immune responses induced by inactivated COVID-19 vaccine has been extensively studied. However, few studies have analyzed the impact of COVID-19 vaccination on innate immune cells.
Yaping Dai (2889992)   +6 more
core   +1 more source

Effectiveness of CoronaVac and BNT162b2 covid-19 mass vaccination in Colombia: a population-based cohort study

open access: yes, 2022
Background: In February 2021, Colombia began mass vaccination against COVID-19 using mainly BNT162b2 and CoronaVac vaccines. We aimed to estimate vaccine effectiveness (VE) to prevent COVID-19 symptomatic cases, hospitalization, critical care admission ...
Hoz-Restrepo, Fernando De La   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy